April 5, 2021 – Shortages of key drugs for children have spurred The Children’s Hospital Coalition, which officially started its work on shortages in March. Phlow Corp. (Richmond, VA) was formed last year by a group of pharmaceutical executives and was awarded $354 million by the Trump administration last May to help produce COVID-19 treatments made in the U.S. The company’s new goal: beginning the process of delivering needed therapies to children’s hospitals within a year. Once the hospitals provide a list of drugs, the company will decide whether it will seek regulatory approval to produce some or all of the drugs itself of contract the work.